Research Article
Simultaneous Integrated Boost Volumetric Modulated Arc Therapy for Rectal Cancer: Long-Term Results after Protocol-Based Treatment
Table 1
Baseline patient and tumor characteristics.
| Characteristics | | (%) |
| Age | | | Mean ± SD | 64 ± 15.4 | | Gender | | | | Male | 15 (68.2) | | Female | 7 (31.8) | ECOG PS | | | | 0 | 16 (72.7) | | 1 | 5 (22.7) | | 2 | 1 (4.5) | cT-stage | | | | cT2 | 1 (4.5) | | cT3 | 17 (77.3) | | cT4a | 1 (4.5) | | cT4b | 3 (13.6) | cN-stage | | | | cN0 | 4 (18.2) | | cN1 | 11 (50) | | cN2 | 7 (31.8) | CEA level | | | Mean ± SD | 15.7 ± 53.4 | | | ≤7 | 17 (77.3) | | >7 | 5 (22.7) | Tumor location (anal verge, cm) | | | Mean ± SD | 4.8 ± 2.4 | | | ≤3 | 6 (27.3) | | >3 | 16 (72.7) |
|
|
ECOG PS: Eastern Cooperative Oncology Group performance status; CEA: carcinoembryonic antigen.
|